Toward noninvasive genomic screening of lung cancer patients.
Lecia V
LV
Sequist
Jeffrey A
JA
Engelman
Thomas J
TJ
Lynch
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000235:genetics*; D004247:DNA / Q000097:blood; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000235:genetics*; D000077156:Gefitinib; D015972:Gene Expression Regulation, Neoplastic; D005820:Genetic Testing; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D008403:Mass Screening / Q000379:methods*; D009154:Mutation; D018579:Patient Selection; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D004247:DNA; C512478:EGFR protein, human; D066246:ErbB Receptors; D000077156:Gefitinib